A42 HETEROGENEITY IN EFFICACY AND SAFETY ENDPOINTS FOR PEDIATRIC CLINICAL TRIALS IN INFLAMMATORY BOWEL DISEASE: A NEED FOR HARMONIZATION

NOT PUBLISHED AT AUTHOR’S REQUEST Funding Agencies: None

Detalles Bibliográficos
Autores principales: Crowley, E, Turner, D, Ma, C, Nguyen, T, McKay, H, Schneider, R, Silverberg, A, Muise, A, Feagan, B, Griffiths, A, Jairath, V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Poster of Distinction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859363/
http://dx.doi.org/10.1093/jcag/gwab049.041

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859363/
http://dx.doi.org/10.1093/jcag/gwab049.041

Ejemplares similares